Zynerba Pharmaceuticals (ZYNE)

[Ihub58]

Totally agree

There is an old saying
“I’d rather be luck than good”
In this case, imo, company’s mgt., unfortunately not so good
Tons of money spent over many years with no real results
But with these findings for the sub group, maybe the shareholders do get lucky, as well as the methylated fragile x patients most importantly